Strong Revenue Growth
Q2 2025 revenue of $146 million, up 8% year-over-year, exceeding the high end of guidance.
EPS Increase
Q2 EPS of $0.24, up 20% year-over-year, above the midpoint of guidance.
Cash Flow and Share Buybacks
Cash from operations of $36 million, exceeding the high end of guidance; repurchased $30 million in shares.
MedTech & Specialty Audio Growth
Revenue of $67 million, up 13% sequentially and 10% year-over-year, driven by demand in Hearing Health and Specialty Audio.
Precision Devices Performance
Revenue of $79 million, up 8% sequentially and 6% year-over-year, with positive bookings trends for three consecutive quarters.
Positive Market Outlook
Expecting continued sequential and year-over-year growth for the remainder of 2025, with strong backlog and order activity.
New Product Lines
Expansion of specialty film production and introduction of a new inductor line to drive future growth.